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ABSTRACT
Background: Many successful attempts at removing
benign mediastinal tumors with the video-assisted thora-
coscopic technique have been reported, but no formal
report has been published regarding malignant mediasti-
nal tumors treated with this technique. We report our
preliminary experience with video-assisted thoracoscop-
ic removal of mediastinal tumors, benign or malignant.
Methods: Seven patients with mediastinal tumors treat-
ed with video-assisted thoracoscopic surgery were
reviewed from January 1999 to April 2000. Their tumor
pathologies included benign or malignant thymoma,
neurilemmoma, and teratoma. 
Results: The mean operation time was 240 minutes. The
mean blood loss was 173 mL. The mean insertion time of
chest tubes was 3 days. The mean admission time was 6
days. No deaths occurred during the study. Morbidity
occurred in 2 patients. No tumor recurrence has been
seen during the mean follow-up of 7 months. 
Conclusions: The short-term results support the feasi-
bility of VATS in managing technically resectable medi-
astinal tumors. Yet the long-term prognosis for the malig-
nant lesions is deferred and needs further study.
Key Words: Video-assisted thoracoscopic surgery,
Thymoma, Neurilemmoma, Teratoma.
INTRODUCTION
Compared with the conventional operation, video-assist-
ed thoracoscopic surgery (VATS) is an alternative method
for managing thoracic diseases and has gradually
become a standard approach to some mediastinal
lesions. Many successful attempts at VATS to remove
benign mediastinal tumors have been reported in the lit-
erature.1-5 With regard to malignant tumors, considering
the possibility of the incomplete resection, most thoracic
surgeons are reluctant to perform VATS resection.5-8
However, with the advancement in video-equipment and
greater experience gained by VATS enthusiasts, it is
appropriate to say that we should try to use VATS to
remove some resectable malignant tumors with a cura-
tive intention. Here is our preliminary report.
MATERIALS AND METHODS
This was a prospective study. All patients with suspected
mediastinal tumors suitable for operation were surveyed
and informed about the procedure of video-assisted tho-
racoscopic surgery (VATS) and the comparison between
the conventional operation and VATS. All the patients
agreed that VATS was to be performed initially and that
it would be continued if the tumor was resectable with
VATS, even if the tumor was malignant. Yet, if it were
impossible to complete the tumor resection with VATS,
an immediate conversion would be performed. From
January 1999 to April 2000, 7 patients were included in
this study. Four patients were included due to thymoma
with or without myasthenia gravis (MG), and 3 patients
were included due to mediastinal cystic tumors (Table
1). The study included 5 women and 2 men. The mean
age was 42 years, with the age ranging from 14 to 65
years.
RESULTS
The right-thoracic approach was used 4 times and the
left-side approach was used 3 times. The mean operation
time was 240 minutes, ranging from 120 to 360 minutes.
The mean blood loss was 173 mL, ranging from 10 mL to
450 mL. All patients were extubated in the recovery
room, except for 2 MG patients who were extubated the
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day after the operation. One or 2 chest tubes were insert-
ed after each VATS procedure, the number of which
depended on the individual condition. The mean inser-
tion time of chest tubes was 3 days, ranging from 1 
day to 11 days. No deaths occurred during the study.
However, morbidity occurred in a patient with benign
thymoma with MG, who was extubated the day after the
operation, but she required reintubation 4 days after the
operation due to progressive dyspnea and required ven-
tilator support for 5 days. She received 1 cycle of plasma-
pheresis, and was ultimately extubated 9 days after the
operation. The other case of morbidity occurred in a
patient with malignant thymoma with MG, who suffered
from chylothorax after the operation. Fortunately, it sub-
sided after conservative treatment. This was the only
patient who needed chest tube insertion longer than 4
days. All patients recovered well, and the mean admis-
sion time was 6 days, ranging from 2 days to 12 days.
Pathologically, of the 4 thymomatous patients in this
study, 1 had the tumor confined in the capsule (Masaoka9
stage I), 2 had microscopic capsular invasion (Masaoka
stage IIA), and 1 had macroscopic capsular invasion
(Masaoka stage IIB) (Table 1). No tumor recurrence has
been seen during the mean follow-up of 7 months, rang-
ing from 2 months to 15 months.
DISCUSSION
The technical goal of thymectomy in the treatment of thy-
moma, with or without MG, is the complete removal of
the tumor and all the related tissues,9-15 which is the same
as that of thymectomy in MG patients.16-18 Currently, 6
surgical techniques exist for performing thymectomy
with different estimated extents of resection18 (Table 2).
Maximal transcervical-transsternal thymectomy is consid-
ered the preferred procedure, which has the most
extended resection, removing 98% to 100% of the thymus
and its related tissues.18-19 Although the resection extent
reached by VATS thymectomy is lower (80% to 85%), it is
almost the same as that reached by the widely performed
extended transsternal thymectomy.20 With the benefit of
minimal access and the acceptable resection extent,20-22
the author considers that an adequate resection can be
performed with VATS that meets both anatomical and
surgical requirements. Therefore, the author prospective-
Table 1.
Seven patients were included in this study.
Patient Sex  Age (years) Tumor location Pathology Size (cm)
1 Male 20 Anterior mediastinum Mature Teratoma 10x6x3.5
2 Female 55 Posterior mediastinum Neurilemmoma 6x3.5x2.3
3 Female 46 Anterior mediastinum Benign Thymoma 6.5x4x1
4 Male 65 Anterior mediastinum Malignant Thymoma* 5.7x4x1.5
5 Female 14 Anterior mediastinum Malignant Thymoma* 7.5x3x1.5
6 Female 50 Posterior mediastinum Neurilemmoma 3.7x2.1x0.6
7 Female 44 Anterior mediastinum Malignant Thymoma† 9x4x2
*Masaoka9 Stage IIA
† Masaoka Stage IIB
Table 2.
Estimated extent of resection.*
Thymectomy technique Extent
“Maximal” transcervical-transsternal 98-100%
“Extended” transsternal 85-95%
VATS resection 80-85%
“Extended” transcervical 75-80%
“Classical” transsternal 70-75%
“Basic” transcervical
45-50%
*Rough estimate.
(From Alfred Jaretzki III. Neurology 1997)18ly tried VATS to remove the thymoma in thymomatous
patients with or without MG. The right thoracic approach
is preferred5 except in the case of obvious left-sided thy-
moma. The existence of thymoma is best detected by
chest computed tomography (CT), with 85% sensitivity,
98.7% specificity, and a 95.8% accuracy rate.23 Chest CT
can also detect tumor invasion of the peripheral tissue or
great vessel involvement, under which condition the
VATS procedure is deemed impractical. Landreneau et
al15 suggest that if a patient has an anterior mediastinal
mass without evidence of local invasion on computed
tomography, exploratory thoracoscopy may be consid-
ered. If thoracoscopy fails to reveal intrathoracic metas-
tases or local invasion, thoracoscopic resection of the
entire lesion may be undertaken.15 However, their VATS
resection of thymoma was limited to Masaoka stage I
only. In the author’s opinion, VATS resection of Masaoka
stage IIA or IIB is not contraindicated if the resection can
remove the entire tumor and the related tissue and if sub-
tle manipulation of tumor tissue to avoid spreading is fol-
lowed, such as protecting the wound from implantation
of a tumor by using a tissue-removing bag. 
Three VATS procedures exist in this study for benign
mediastinal cystic tumors. One of the benign cystic
tumors is a huge mature teratoma with a diameter of 10
x 6 x 3.5 cm.24 It seems that a huge-sized cystic lesion is
not a contraindication to VATS. In a previous report1 of
multicenter VATS experience with mediastinal tumors,
the conclusion was that video-assisted thoracic surgery is
a safe technique for benign mediastinal tumors, typically
for those in the middle and posterior mediastinum. The
author believes that in the anterior mediastinum, VATS is
also a safe technique.
Surely, this preliminary report has a limited number of
cases, and follow-up duration is not long enough.
Further observation is needed to verify the role of VATS
in the management of mediastinal tumors, especially
malignant ones. 
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